• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大艾伯塔省 1988 年至 2007 年隆凸性皮肤纤维肉瘤的流行病学研究。

Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988 to 2007.

机构信息

Division of Dermatology and Cutaneous Sciences, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Dermatol Surg. 2012 Sep;38(9):1461-8. doi: 10.1111/j.1524-4725.2012.02482.x. Epub 2012 Jun 12.

DOI:10.1111/j.1524-4725.2012.02482.x
PMID:22691126
Abstract

BACKGROUND

There have only been a few population-based, epidemiologic studies assessing dermatofibrosarcoma protuberans (DFSP).

OBJECTIVE

To assess the epidemiology of DFSP in Alberta, Canada, over a 20-year period.

METHODS

A population-based, retrospective analysis of all cases of DFSP in Alberta was conducted using data from the Alberta Cancer Registry. Sex-, age-, and anatomical location-specific incidence rates and trends were determined.

RESULTS

The overall age-standardized incidence rate of DFSP remained stable at 0.93 per 100,000. DFSP prevalence was highest in individuals aged 20 to 39 (46.8%), followed by those aged 40 to 59 (34.0%), 60 and older (14.7%), and lastly younger than 20 (4.5%). The mean age at diagnosis was 41.1 (women) and 43.1 (men). The incidence of DFSP in men and women has shown a dramatic shift such that incidence in women has increased 3.2% per year, whereas in men it has decreased 2.7% per year. In women, DFSP incidence increased on the trunk and decreased on the upper extremities.

CONCLUSION

The age-standardized incidence of DFSP observed is nearly twice as high as previously reported and has remained stable. The incidence is increasing in women and decreasing in men. DFSP primarily affects young to middle-aged adults and most commonly presents on the trunk.

摘要

背景

仅有少数几项基于人群的流行病学研究评估了隆凸性皮肤纤维肉瘤(DFSP)。

目的

在 20 年的时间里,评估加拿大艾伯塔省 DFSP 的流行病学情况。

方法

使用艾伯塔癌症登记处的数据,对艾伯塔省所有 DFSP 病例进行了一项基于人群的回顾性分析。确定了特定性别、年龄和解剖部位的发病率和趋势。

结果

DFSP 的总体年龄标准化发病率保持稳定,为每 10 万人中有 0.93 人。DFSP 的流行率在 20 至 39 岁人群中最高(46.8%),其次是 40 至 59 岁人群(34.0%)、60 岁及以上人群(14.7%)以及 20 岁以下人群(4.5%)。诊断时的平均年龄为女性 41.1 岁,男性 43.1 岁。男性和女性中 DFSP 的发病率都发生了显著变化,女性的发病率每年增加 3.2%,而男性则每年减少 2.7%。在女性中,DFSP 的发病率在躯干上增加,在上肢上减少。

结论

观察到的 DFSP 年龄标准化发病率几乎是先前报道的两倍,且保持稳定。发病率在女性中增加,在男性中减少。DFSP 主要影响年轻至中年成年人,最常见于躯干。

相似文献

1
Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988 to 2007.加拿大艾伯塔省 1988 年至 2007 年隆凸性皮肤纤维肉瘤的流行病学研究。
Dermatol Surg. 2012 Sep;38(9):1461-8. doi: 10.1111/j.1524-4725.2012.02482.x. Epub 2012 Jun 12.
2
Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.隆突性皮肤纤维肉瘤:一项基于人群的癌症登记描述性研究,涉及1982年至2002年间连续诊断的66例病例。
J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1237-42. doi: 10.1111/j.1468-3083.2006.01780.x.
3
The epidemiology of dermatofibrosarcoma protuberans incidence, metastasis, and death among various population groups: A Surveillance, Epidemiology, and End Results database analysis.隆突性皮肤纤维肉瘤的流行病学:在不同人群中发病率、转移和死亡的分析:一项监测、流行病学和最终结果数据库分析。
J Am Acad Dermatol. 2024 Nov;91(5):826-833. doi: 10.1016/j.jaad.2024.05.088. Epub 2024 Jun 21.
4
Dermatofibrosarcoma protuberans: a clinicopathological study in an African population.
East Afr Med J. 1996 Jun;73(6):410-3.
5
Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.隆突性皮肤纤维肉瘤:29例采用莫氏显微外科手术治疗患者的报告及长期随访与文献复习
Cancer. 2004 Jul 1;101(1):28-38. doi: 10.1002/cncr.20316.
6
Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.隆突性皮肤纤维肉瘤手术后的低复发率:来自单一机构的多学科方法。
Cancer. 2004 Mar 1;100(5):1008-16. doi: 10.1002/cncr.20051.
7
Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.隆突性皮肤纤维肉瘤(DFSP)诊断后的继发原发性恶性肿瘤风险:一项全国性研究。
J Am Acad Dermatol. 2013 May;68(5):790-6. doi: 10.1016/j.jaad.2012.10.040. Epub 2012 Dec 21.
8
Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤前突出期的临床变体
Br J Dermatol. 2005 Nov;153(5):932-6. doi: 10.1111/j.1365-2133.2005.06823.x.
9
Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States.美国原发性隆突性皮肤纤维肉瘤的发病率与生存率
Dermatol Surg. 2016 Jan;42 Suppl 1:S24-31. doi: 10.1097/DSS.0000000000000300.
10
Incidence and Outcomes of Dermatofibrosarcoma Protuberans in the US Pediatric Population.美国儿科人群中隆突性皮肤纤维肉瘤的发病率及预后
J Craniofac Surg. 2017 Jan;28(1):182-184. doi: 10.1097/SCS.0000000000003203.

引用本文的文献

1
Relative Tumor Density of Soft-Tissue Sarcoma in Korean Population: An Institutional Review.韩国人群软组织肉瘤的相对肿瘤密度:一项机构回顾
Ann Dermatol. 2025 Apr;37(2):96-104. doi: 10.5021/ad.23.122.
2
Dermatofibrosarcoma Protuberans: An Updated Review of the Literature.隆突性皮肤纤维肉瘤:文献综述更新
Cancers (Basel). 2024 Sep 11;16(18):3124. doi: 10.3390/cancers16183124.
3
Additional Wide Resection of Infantile Dermatofibrosarcoma Protuberans after Unplanned Excision: A Case Report.婴儿型隆突性皮肤纤维肉瘤意外切除术后的额外广泛切除术:病例报告
Case Rep Oncol. 2023 Jul 3;16(1):331-339. doi: 10.1159/000530639. eCollection 2023 Jan-Dec.
4
The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications.性与性别在皮肤病学中的作用——从发病机制到临床意义。
J Cutan Med Surg. 2023 Jul-Aug;27(4):NP1-NP36. doi: 10.1177/12034754231177582. Epub 2023 Jul 4.
5
Dermatofibrosarcoma protuberans (DFSP) arising from a keloid scar - A case report.源于瘢痕疙瘩的隆突性皮肤纤维肉瘤——1例病例报告
JPRAS Open. 2018 Oct 2;18:65-69. doi: 10.1016/j.jpra.2018.09.002. eCollection 2018 Dec.
6
The efficacy of Mohs micrographic surgery over the traditional wide local excision surgery in the cure of dermatofibrosarcoma protuberans.莫氏显微外科手术相较于传统广泛局部切除手术治疗隆突性皮肤纤维肉瘤的疗效。
Pan Afr Med J. 2019 Aug 13;33:297. doi: 10.11604/pamj.2019.33.297.17692. eCollection 2019.